152 related articles for article (PubMed ID: 32912437)
1. Design, synthesis and biological evaluation of 4-aryl-5-aminoalkyl-thiazole-2-amines derivatives as ROCK II inhibitors.
Ma S; Wang L; Ouyang B; Fan M; Qi J; Yao L
Bioorg Med Chem; 2020 Oct; 28(19):115683. PubMed ID: 32912437
[TBL] [Abstract][Full Text] [Related]
2. The Design, Synthesis and Evaluation of Rho-kinase Inhibitory Activity of 4-aryl-thiazole-2-amines.
Wang L; Ouyang B; Fan M; Qi J; Yao L
Iran J Pharm Res; 2021; 20(3):121-131. PubMed ID: 34903975
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and biological evaluation of urea-based ROCK2 inhibitors.
Wang L; Qi J; Fan M; Yao L
Chem Biol Drug Des; 2021 Dec; 98(6):969-978. PubMed ID: 34581498
[TBL] [Abstract][Full Text] [Related]
4. A combine approach of chemical synthesis, biological evaluation and structural dynamics studies revealed thiazole substituted arylamine derivatives as potent FabH enzyme inhibitors.
Ahmad H; Ahmad F; Parveen S; Ahmad S; Azam SS; Hassan A
Bioorg Chem; 2020 Dec; 105():104426. PubMed ID: 33161255
[TBL] [Abstract][Full Text] [Related]
5. ROCK inhibitors 4: Structure-activity relationship studies of 7-azaindole-based rho kinase (ROCK) inhibitors.
Bandarage UK; Court J; Gao H; Nanthakumar S; Come JH; Giroux S; Green J
Bioorg Med Chem Lett; 2021 Feb; 33():127721. PubMed ID: 33259926
[TBL] [Abstract][Full Text] [Related]
6. Design and synthesis of benzimidazole-based Rho kinase inhibitors for the treatment of glaucoma.
Abbhi V; Saini L; Mishra S; Sethi G; Kumar AP; Piplani P
Bioorg Med Chem; 2017 Nov; 25(21):6071-6085. PubMed ID: 29033348
[TBL] [Abstract][Full Text] [Related]
7. Modification of imidazothiazole derivatives gives promising activity in B-Raf kinase enzyme inhibition; synthesis, in vitro studies and molecular docking.
Ammar UM; Abdel-Maksoud MS; Mersal KI; Ali EMH; Yoo KH; Choi HS; Lee JK; Cha SY; Oh CH
Bioorg Med Chem Lett; 2020 Oct; 30(20):127478. PubMed ID: 32781217
[TBL] [Abstract][Full Text] [Related]
8. Fragment-based discovery of 6-substituted isoquinolin-1-amine based ROCK-I inhibitors.
Ray P; Wright J; Adam J; Bennett J; Boucharens S; Black D; Cook A; Brown AR; Epemolu O; Fletcher D; Haunso A; Huggett M; Jones P; Laats S; Lyons A; Mestres J; de Man J; Morphy R; Rankovic Z; Sherborne B; Sherry L; van Straten N; Westwood P; Zaman GZ
Bioorg Med Chem Lett; 2011 Jan; 21(1):97-101. PubMed ID: 21145740
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, in vitro antiproliferative evaluation, and kinase inhibitory effects of a new series of imidazo[2,1-b]thiazole derivatives.
Abdel-Maksoud MS; Kim MR; El-Gamal MI; Gamal El-Din MM; Tae J; Choi HS; Lee KT; Yoo KH; Oh CH
Eur J Med Chem; 2015 May; 95():453-63. PubMed ID: 25841200
[TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of novel thiazole-derivatives as potent ALK5 inhibitors.
Arai M; Hanada M; Moriyama H; Ohmoto H; Miyake T; Naka K; Sawa M
Bioorg Med Chem Lett; 2024 Aug; 108():129797. PubMed ID: 38759932
[TBL] [Abstract][Full Text] [Related]
11. Benzothiazoles as Rho-associated kinase (ROCK-II) inhibitors.
Yin Y; Lin L; Ruiz C; Cameron MD; Pocas J; Grant W; Schröter T; Chen W; Duckett D; Schürer S; Lograsso P; Feng Y
Bioorg Med Chem Lett; 2009 Dec; 19(23):6686-90. PubMed ID: 19837589
[TBL] [Abstract][Full Text] [Related]
12. ROCK inhibitors 3: Design, synthesis and structure-activity relationships of 7-azaindole-based Rho kinase (ROCK) inhibitors.
Bandarage UK; Cao J; Come JH; Court JJ; Gao H; Jacobs MD; Marhefka C; Nanthakumar S; Green J
Bioorg Med Chem Lett; 2018 Aug; 28(15):2622-2626. PubMed ID: 30082069
[TBL] [Abstract][Full Text] [Related]
13. Effects of newly synthetized isoquinoline derivatives on rat uterine contractility and ROCK II activity.
Domokos D; Fülöp F; Falkay G; Gáspár R
Bioorg Med Chem Lett; 2018 Feb; 28(3):466-469. PubMed ID: 29269216
[TBL] [Abstract][Full Text] [Related]
14. Optimisation of 6-substituted isoquinolin-1-amine based ROCK-I inhibitors.
Ray P; Wright J; Adam J; Boucharens S; Black D; Brown AR; Epemolu O; Fletcher D; Huggett M; Jones P; Laats S; Lyons A; de Man J; Morphy R; Sherborne B; Sherry L; Straten Nv; Westwood P; York M
Bioorg Med Chem Lett; 2011 Feb; 21(4):1084-8. PubMed ID: 21251828
[TBL] [Abstract][Full Text] [Related]
15. 5-Benzylidene-2,4-thiazolidenedione derivatives: Design, synthesis and evaluation as inhibitors of angiogenesis targeting VEGR-2.
Bhanushali U; Rajendran S; Sarma K; Kulkarni P; Chatti K; Chatterjee S; Ramaa CS
Bioorg Chem; 2016 Aug; 67():139-47. PubMed ID: 27388635
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and biological evaluation of a new series of thiazolyl-pyrazolines as dual EGFR and HER2 inhibitors.
Sever B; Altıntop MD; Radwan MO; Özdemir A; Otsuka M; Fujita M; Ciftci HI
Eur J Med Chem; 2019 Nov; 182():111648. PubMed ID: 31493743
[TBL] [Abstract][Full Text] [Related]
17. Design, Synthesis, and Structure-Activity Relationships of Pyridine-Based Rho Kinase (ROCK) Inhibitors.
Green J; Cao J; Bandarage UK; Gao H; Court J; Marhefka C; Jacobs M; Taslimi P; Newsome D; Nakayama T; Shah S; Rodems S
J Med Chem; 2015 Jun; 58(12):5028-37. PubMed ID: 26039570
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of N-aryl-4-aryl-1,3-thiazole-2-amine derivatives as direct 5-lipoxygenase inhibitors.
Suh J; Yum EK; Cheon HG; Cho YS
Chem Biol Drug Des; 2012 Jul; 80(1):89-98. PubMed ID: 22404847
[TBL] [Abstract][Full Text] [Related]
19. A review on ROCK-II inhibitors: From molecular modelling to synthesis.
Shah S; Savjani J
Bioorg Med Chem Lett; 2016 May; 26(10):2383-2391. PubMed ID: 27080184
[TBL] [Abstract][Full Text] [Related]
20. Design of Aminobenzothiazole Inhibitors of Rho Kinases 1 and 2 by Using Protein Kinase A as a Structure Surrogate.
Judge RA; Vasudevan A; Scott VE; Simler GH; Pratt SD; Namovic MT; Putman CB; Aguirre A; Stoll VS; Mamo M; Swann SI; Cassar SC; Faltynek CR; Kage KL; Boyce-Rustay JM; Hobson AD
Chembiochem; 2018 Mar; 19(6):613-621. PubMed ID: 29314498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
